Neeharika Krothapalli

Neeharika Krothapalli

Auto-generated profile, based on publicly available information

Neeharika Krothapalli

Stanford School of Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2023 in World Neurosurgery
Verified
Journal Article
Closed access
NKNeeharika Krothapalli
Neeharika Krothapalli
SPSmit Patel
Smit Patel
MFMohamad Fayad
Mohamad Fayad
AEAhmed Elmashad
Ahmed Elmashad
BKBrendan Killory
Brendan Killory
TMTapan Mehta
Tapan Mehta

23 December 2025 in Neurology
Verified
Journal Article
Closed access
LDLayne Dylla
Layne Dylla
NKNeeharika Krothapalli
Neeharika Krothapalli
LTLong Tu
Long Tu
Sam PayabvashSam Payabvash
Sam Payabvash
JBJames F. Burke
James F. Burke
AHAdam de Havenon
Adam de Havenon
Head CT is an essential element of emergency department (ED) diagnosis and treatment of numerous neurologic emergencies. However, it is costly in aggregate, exposes patients to ionizing radiation, and can contribute to increased ED delays and length of stay. The objective of this study was to characterize head CT use in a nationwide sample of EDs between 2007 and 2022. This is a retrospective cohort analysis of the National Hospital Ambulatory Medical Care Survey (NHAMCS) database from 2007 to 2022. We used multivariable logistic regression to determine the odds of an ED encounter receiving a CT scan of the head, applying NHAMCS survey weights. Study exposures included year, patient demographics, and hospital characteristics. To explore differential trends over time, we created interaction terms between year and patient age, sex, and race/ethnicity. In 2007, the weighted number of ED encounters that received a head CT was 7,841,855 (95% CI 6,328,471-9,355,239), and by 2022, it had more than doubled to 15,977,551 (95% CI 12,343,286-19,611,816) (p < 0.001 for difference), representing an increase from 6.7% to 10.3% of ED encounters. We did not find a significant interaction between time (years) and sex, but the interaction between time and age was highly significant (p < 0.001). Patients aged 65 years or older had 6.24 (95% CI 5.66-6.88) times the odds of receiving a head CT compared with patients aged younger than 18 years after controlling for year, month, and chief concern at ED admission. Patients who were Black (OR 0.90, 95% CI 0.85-0.96), on Medicaid (OR 0.82, 95% CI 0.77-0.87), or from a rural hospital (OR 0.76, 95% CI 0.70-0.83) were less likely to receive a head CT. The overall number of head CT scans during an ED encounter increased more than twofold from 7.8 to 16 million during 2007-2022. Racial, insurance, and geographic variations continue to exist in head CT usage. Given increasing rates of head CT scans in the ED, additional evaluation of their yield in comparison with the relative risks and costs is needed.

29 March 2021 in Cureus
Verified
Journal Article
Open access
NKNeeharika Krothapalli
Neeharika Krothapalli
JJJason Jacob
Jason Jacob
Severe respiratory syndrome coronavirus 2 (SARS-CoV-2) is well known for causing respiratory and other extrapulmonary manifestations. Patients infected with coronavirus disease 2019 (COVID-19) may demonstrate atypical presentations with gastrointestinal symptoms. Clinicians managing these patients should reserve a high index of suspicion for the rare complication of acute mesenteric ischemia (AMI). It is a challenging diagnosis that is often missed when presenting symptoms are subtle and nonspecific like nausea, emesis, or diarrhea. Outcomes are typically catastrophic and fatal as bowel ischemia progresses to necrosis but may be averted with timely diagnostic and therapeutic methods to swiftly restore blood flow.

7 August 2025 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
NKNeeharika Krothapalli
Neeharika Krothapalli
JHJeremy J Heit
Jeremy J Heit
AHAdam de Havenon
Adam de Havenon
ASAneesh B Singhal
Aneesh B Singhal
ESEric Sussman
Eric Sussman
BGBrian Mac Grory
Brian Mac Grory
Tandem occlusions (TOs)—concurrent extracranial large artery steno-occlusion and intracranial artery occlusion—represent a challenging clinical predicament. Stroke due to TOs is associated with high mortality and morbidity. Because of increased clot burden compared with single occlusions and impaired anterograde flow, intravenous thrombolysis may be less effective, and outcomes are poor without timely intervention. Endovascular thrombectomy (EVT) has become the cornerstone of intracranial revascularization, but the optimal management of the extracranial carotid lesion remains undefined. Evidence from observational studies and early-phase randomized controlled trials (RCTs) is mixed. Currently, no standardized treatment approach is widely accepted, and practice patterns are guided by personal preference and expert opinion. Ongoing RCTs seek to determine whether there is an optimal approach to EVT in the setting of TO with respect to (a) technique and (b) the order of treatment. Even on completion of active RCTs, a dearth of evidence will remain on the optimal antithrombotic therapy, exact device selection, and EVT in dissection-associated TOs and posterior circulation TOs. In the present narrative review, we critically appraise the literature on the endovascular management of TOs and offer considerations for practice that may help to reduce the burden of tandem occlusion strokes.

1 January 2023 in Brain Circulation
Verified
Journal Article
Open access
PDF file
NKNeeharika Krothapalli
Neeharika Krothapalli
MFMohamad Fayad
Mohamad Fayad
ESEric Sussman
Eric Sussman
CBCharles Bruno
Charles Bruno
MOMartin Ollenschleger
Martin Ollenschleger
TMTapan Mehta
Tapan Mehta
Carotid cavernous fistulas (CCFs) are a rare but debilitating entity that may present with orbital or cerebral venous hypertension. CCFs may pose diagnostic and management pitfalls for clinicians as they can initially be misdiagnosed as primary orbital pathology or nonarteriovenous shunting-related cavernous sinus pathology. Furthermore, the resolution of pulsatile tinnitus could be an ominous sign in patients with untreated dural arteriovenous fistula. We describe a case of a 56-year-old male who presented with progressive right eye proptosis, congestion, decreased visual acuity, limited duction, exophthalmos, and pulsatile tinnitus. The patient had poor response to antibiotics and steroids. Magnetic resonance imaging brain showed significant inflammation involving the right orbit and atypical enhancement of the basal frontal lobe adjacent to the orbit. Cerebral angiography revealed an indirect right CCF and right sigmoid sinus thrombosis with stenosis of the right internal jugular vein. No clear predisposing factor was identified. Given the rapidly progressive nature of the condition, the patient successfully underwent endovascular treatment with transvenous approach to preserve flow in the internal carotid artery while ensuring occlusion of the fistula. A triad of proptosis, eye congestion, and signs of turbulent flow such as tinnitus or orbital bruit should raise suspicion for CCF. An interesting feature in this patient is that CCF may have occurred secondary to sigmoid sinus thrombosis with accompanying small cortical vein drainage. Our case highlights the importance of early recognition and timely intervention to ensure the resolution of orbital hypertension-related symptoms in rare cases of CCFs.

15 November 2022 in The Neurologist
Verified
Journal Article
Closed access
RKRyan Do Kollar
Ryan Do Kollar
SPSmit D. Patel
Smit D. Patel
NKNeeharika Do Krothapalli
Neeharika Do Krothapalli
LYLulu E. Yan
Lulu E. Yan
IDIan Dimaandal
Ian Dimaandal
DWDavid Waitzman
David Waitzman
Introduction: Optic perineuritis (OPN) is a previously undescribed sequela of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here we present a case of OPN that developed several weeks after initial confirmation of the presence of novel coronavirus RNA in the nasopharynx by polymerase chain reaction assay and subsequent confirmation of SARS-CoV-2 IgG seropositivity in the absence of other systemic inflammatory or infectious markers. Case Report: An asymptomatic 71-year-old man with noninsulin-dependent diabetes mellitus (NIDDM) tested RNA positive for SARS-CoV-2 during a routine screening of patients at a skilled nursing facility. ~3 weeks after the positive SARS-CoV-2 polymerase chain reaction test, the patient developed subacute ophthalmoparesis of the left eye, horizontal diplopia, retro-orbital pain, and frontal headache. An urgent magnetic resonance imaging of the head and orbits suggested OPN. Cerebrospinal fluid studies were without evidence of other infectious, inflammatory, neoplastic, or paraneoplastic processes. He was started on a 5-day course of high-dose intravenous steroids and later transitioned to oral steroid therapy. Sixteen days after the initiation of steroid therapy, the patient had no headache or retro-orbital pain and demonstrated a marked improvement in horizontal gaze. Conclusion: SARS-CoV-2-associated neurological sequelae have been increasingly recognized during the current coronavirus disease 2019 pandemic. The present case suggests that patients with confirmed SARS-CoV-2 positivity, even without pulmonary or other classic manifestations of active infection, may manifest diverse clinical presentations including postinfectious OPN that could be related to an underlying autoimmune reactive inflammatory response.